Acer Therapeutics Inc (ACER)

Acer Therapeutics (ACER) Stock Price & Analysis


ACER Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.65 - $4.56
Previous Close$0.89
Average Volume (3M)333.93K
Market Cap
Enterprise Value$26.72M
Total Cash (Recent Filing)$6.40M
Total Debt (Recent Filing)$11.40M
Price to Earnings (P/E)-0.5
Aug 15, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.80
Shares Outstanding24,300,073
10 Day Avg. Volume197,639
30 Day Avg. Volume333,928
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)-0.49
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.88
Price Target Upside1242.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Acer Therapeutics Inc’s price range in the past 12 months?
Acer Therapeutics Inc lowest stock price was $0.65 and its highest was $4.56 in the past 12 months.
    What is Acer Therapeutics Inc’s market cap?
    Currently, no data Available
    When is Acer Therapeutics Inc’s upcoming earnings report date?
    Acer Therapeutics Inc’s upcoming earnings report date is Aug 15, 2023 which is in 72 days.
      How were Acer Therapeutics Inc’s earnings last quarter?
      Acer Therapeutics Inc released its earnings results on May 15, 2023. The company reported -$0.77 earnings per share for the quarter, missing the consensus estimate of -$0.285 by -$0.485.
        Is Acer Therapeutics Inc overvalued?
        According to Wall Street analysts Acer Therapeutics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Acer Therapeutics Inc pay dividends?
          Acer Therapeutics Inc does not currently pay dividends.
          What is Acer Therapeutics Inc’s EPS estimate?
          Acer Therapeutics Inc’s EPS estimate is -$0.25.
            How many shares outstanding does Acer Therapeutics Inc have?
            Acer Therapeutics Inc has 24,300,074 shares outstanding.
              What happened to Acer Therapeutics Inc’s price movement after its last earnings report?
              Acer Therapeutics Inc reported an EPS of -$0.77 in its last earnings report, missing expectations of -$0.285. Following the earnings report the stock price went up 2.632%.
                Which hedge fund is a major shareholder of Acer Therapeutics Inc?
                Currently, no hedge funds are holding shares in ACER


                Acer Therapeutics Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Acer Therapeutics Inc

                Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded by Christopher Schelling in September 2017 and is headquartered in Newton, MA.


                Top 5 ETFs holding ACER

                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                iShares Core S&P Total U.S. Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold ACER. The ETFs are listed according to market value of ACER within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Apellis Pharmaceuticals
                Kala Pharmaceuticals
                Mersana Therapeutics

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis